{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:58:29Z","timestamp":1783033109614,"version":"3.54.6"},"reference-count":156,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01172","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T11:52:38Z","timestamp":1539863558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia"],"prefix":"10.3389","volume":"9","author":[{"given":"Candice E.","family":"Crocker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Tibbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e18652","DOI":"10.1371\/journal.pone.0018652","article-title":"Regionally specific white matter disruptions of fornix and cingulum in schizophrenia","volume":"6","author":"Abdul-Rahman","year":"2011","journal-title":"PLOS ONE"},{"key":"B2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/0706743717720197","article-title":"Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth","volume":"62","author":"Abidi","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1176\/appi.ps.201200156","article-title":"Essential evidence-based components of first-episode psychosis services","volume":"64","author":"Addington","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.1523\/JNEUROSCI.3185-16.2017","article-title":"On myelinated axon plasticity and neuronal circuit formation and function","volume":"37","author":"Almeida","year":"2017","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"pyv016","DOI":"10.1093\/ijnp\/pyv016","article-title":"Extensive Gray matter volume reduction in treatment-resistant schizophrenia","volume":"18","author":"Anderson","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"32603","DOI":"10.1074\/jbc.M403429200","article-title":"Sialyltransferase St8sia-Ii assembles a subset of polysialic acid that directs hippocampal axonal targeting and promotes fear behavior","volume":"279","author":"Angata","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/ijms18081760","article-title":"Multiple sclerosis and schizophrenia","volume":"18","author":"Arneth","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B10","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jnr.20208","article-title":"Microarray analysis of postmortem temporal cortex from patients with schizophrenia","volume":"77","author":"Aston","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.scog.2018.02.001","article-title":"Cognitive and psychopathology correlates of brain white\/grey matter structure in severely psychotic schizophrenic inpatients","volume":"12","author":"Banaj","year":"2018","journal-title":"Schizophr. Res. Cogn."},{"key":"B12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fnana.2017.00119","article-title":"The superior fronto-occipital fasciculus in the human brain revealed by diffusion spectrum imaging tractography: an anatomical reality or a methodological artifact?","volume":"11","author":"Bao","year":"2017","journal-title":"Front. Neuroanat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/nbm.782","article-title":"The basis of anisotropic water diffusion in the nervous system - a technical review","volume":"15","author":"Beaulieu","year":"2002","journal-title":"NMR Biomed."},{"key":"B14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/NEN.0b013e3181aba2c1","article-title":"Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells","volume":"68","author":"Bernardo","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.schres.2014.01.015","article-title":"White matter pathway organization of the reward system is related to positive and negative symptoms in schizophrenia","volume":"153","author":"Bracht","year":"2014","journal-title":"Schizophr. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2009.12.012","article-title":"White matter abnormalities in first-episode schizophrenia: a combined structural MRI and DTI study","volume":"119","author":"Chan","year":"2010","journal-title":"Schizophr. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4103\/0366-6999.228233","article-title":"Specific white matter impairments in patients with treatment-refractory first-episode schizophrenia: a 1-year follow-up pilot study","volume":"131","author":"Chen","year":"2018","journal-title":"Chin. Med. J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1038\/srep07458","article-title":"n-3 PUFA supplementation benefits microglial responses to myelin pathology","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"B20","volume-title":"Chinese Medical Association: [Guideline For The Prevention and Treatment of Schizophrenia in China]","year":"2003"},{"key":"B21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12883-017-0949-4","article-title":"Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability","volume":"17","author":"Chu","year":"2017","journal-title":"BMC Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jon.12271","article-title":"Whole brain volume measured from 1.5t versus 3t MRI in healthy subjects and patients with multiple sclerosis","volume":"26","author":"Chu","year":"2016","journal-title":"J. Neuroimag."},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (Fty720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/B978-0-12-800756-3.00041-7","article-title":"Neuroimaging findings in adolescent cannabis use and early phase psychosis","volume-title":"Handbook of Cannabis and Related Pathologies: Biology, Diagnosis, Treatment and Pharmacology","author":"Crocker","year":"2017"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4050536","DOI":"10.1155\/2017\/4050536","article-title":"White matter hyperintensity load modulates brain morphometry and brain connectivity in healthy adults: a neuroplastic mechanism?","volume":"2017","author":"De Marco","year":"2017","journal-title":"Neural Plasticity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroscience.2016.01.028","article-title":"Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice","volume":"318","author":"Dehghan","year":"2016","journal-title":"Neuroscience"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1017\/S0033291717000435","article-title":"Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors","volume":"47","author":"Demjaha","year":"2017","journal-title":"Psychol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1017\/S0033291717001313","article-title":"White Matter connectivity disruptions in early and chronic schizophrenia","volume":"47","author":"Di Biase","year":"2017","journal-title":"Psychol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1177\/0004867417699473","article-title":"Structural brain changes in schizophrenia at different stages of the illness: a selective review of longitudinal magnetic resonance imaging studies","volume":"51","author":"Dietsche","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1002\/jcp.26301","article-title":"Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial","volume":"233","author":"Dolati","year":"2018","journal-title":"J. Cell Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41467-018-03427-1","article-title":"Vesicular glutamate release from central axons contributes to myelin damage","volume":"9","author":"Doyle","year":"2018","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.psc.2016.01.006","article-title":"Treatment-resistant schizophrenia","volume":"39","author":"Elkis","year":"2016","journal-title":"Psychiatr. Clin. North. Am."},{"key":"B34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.nicl.2013.03.006","article-title":"Diffuse reduction of white matter connectivity in cerebral palsy with specific vulnerability of long range fiber tracts","volume":"2","author":"Englander","year":"2013","journal-title":"NeuroImage Clin."},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/schbul\/22.1.15","article-title":"Clozapine eligibility among state hospital patients","volume":"22","author":"Essock","year":"1996","journal-title":"Schizophr. Bull."},{"key":"B36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"B37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.schres.2008.10.022","article-title":"Diffusion tractography of the fornix in schizophrenia","volume":"107","author":"Fitzsimmons","year":"2009","journal-title":"Schizophr. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2016.07.014","article-title":"The dysconnection hypothesis","volume":"176","author":"Friston","year":"2016","journal-title":"Schizophr. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1324","DOI":"10.1212\/WNL.0000000000005292","article-title":"Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis","volume":"90","author":"Gaetano","year":"2018","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3389\/fnhum.2014.00671","article-title":"Whole brain myelin mapping using T1- and T2-weighted MR imaging data","volume":"8","author":"Ganzetti","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","article-title":"Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: biochemical and histological study","volume":"54","author":"Ghaiad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1523\/JNEUROSCI.2180-11.2011","article-title":"Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI","volume":"31","author":"Glasser","year":"2011","journal-title":"J. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.brainres.2010.03.007","article-title":"Minocycline treatment reduces white matter damage after excitotoxic striatal injury","volume":"1329","author":"Guimaraes","year":"2010","journal-title":"Brain Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jnc.12964","article-title":"Polyphenols from green tea prevent antineuritogenic action of Nogo-A via 67-kDa laminin receptor and hydrogen peroxide","volume":"132","author":"Gundimeda","year":"2015","journal-title":"J. Neurochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/emmm.201200230","article-title":"A myelin gene causative of a catatonia-depression syndrome upon aging","volume":"4","author":"Hagemeyer","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e88506","DOI":"10.1371\/journal.pone.0088506","article-title":"Disc1 (Disrupted-In-Schizophrenia-1) Regulates differentiation of oligodendrocytes","volume":"9","author":"Hattori","year":"2014","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2005.06.054","article-title":"Interleukin-10\u22121082 promoter polymorphism is associated with schizophrenia in a Han Chinese sib-pair study","volume":"394","author":"He","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B52","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/npp.2013.294","article-title":"Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia","volume":"39","author":"Holleran","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pscychresns.2005.07.004","article-title":"Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder","volume":"140","author":"Hoptman","year":"2005","journal-title":"Psychiatry Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/hbm.23982","article-title":"Shared and distinct alterations of white matter tracts in remitted and nonremitted patients with schizophrenia","volume":"39","author":"Huang","year":"2018","journal-title":"Hum. Brain Mapp"},{"key":"B56","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neuroimage.2018.03.023","article-title":"Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults-A randomized controlled trial","volume":"174","author":"Huhn","year":"2018","journal-title":"Neuroimage"},{"key":"B57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hup.2517","article-title":"The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial","volume":"31","author":"Iranpour","year":"2016","journal-title":"Hum. Psychopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00406-014-0547-z","article-title":"Structural connectivity of the salience-executive loop in schizophrenia","volume":"265","author":"Iwabuchi","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"E00399","DOI":"10.1002\/brb3.399","article-title":"Use of T1-weighted\/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain","volume":"5","author":"Iwatani","year":"2015","journal-title":"Brain Behav."},{"key":"B60","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1172\/JCI97032","article-title":"Microglia ablation alleviates myelin-associated catatonic signs in mice","volume":"128","author":"Janova","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1176\/ps.46.8.801","article-title":"Effects of stringent criteria on eligibility for clozapine among public mental health clients","volume":"46","author":"Juarez-Reyes","year":"1995","journal-title":"Psychiatr. Serv."},{"key":"B62","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. General Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1017\/S0033291714001111","article-title":"Processing speed impairment in schizophrenia is mediated by white matter integrity","volume":"45","author":"Karbasforoushan","year":"2015","journal-title":"Psychol. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1756285617708911","article-title":"MRI in the assessment and monitoring of multiple sclerosis: an update on best practice","volume":"10","author":"Kaunzner","year":"2017","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"B66","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1176\/ajp.144.7.889","article-title":"Characteristics of very poor outcome schizophrenia","volume":"144","author":"Keefe","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.euroneuro.2017.12.117","article-title":"Gray and white matter changes and their relation to illness trajectory in first episode psychosis","volume":"28","author":"Keymer-Gausset","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.14348\/molcells.2015.0246","article-title":"Promotion of remyelination by sulfasalazine in a transgenic zebrafish model of demyelination","volume":"38","author":"Kim","year":"2015","journal-title":"Mol. Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/1352458512438723","article-title":"Fty720 on the way from the base camp to the summit of the mountain: relevance for remyelination","volume":"18","author":"Kipp","year":"2012","journal-title":"Mult. Scler."},{"key":"B71","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/schbul\/sbw100","article-title":"White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs","volume":"43","author":"Klauser","year":"2017","journal-title":"Schizophr. Bull."},{"key":"B72","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamapsychiatry.2017.2228","article-title":"Association of white matter with core cognitive deficits in patients with schizophrenia","volume":"74","author":"Kochunov","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2010.08.070","article-title":"Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaiv","volume":"171","author":"Koutsoudaki","year":"2010","journal-title":"Neuroscience"},{"key":"B74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00429-013-0638-z","article-title":"Schizophrenia-like phenotype of polysialyltransferase St8sia2-deficient mice","volume":"220","author":"Krocher","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"B75","doi-asserted-by":"publisher","first-page":"Pyu051","DOI":"10.1093\/ijnp\/pyu051","article-title":"Oxytocin affects the connectivity of the precuneus and the amygdala: a randomized, double-blinded, placebo-controlled neuroimaging trial","volume":"18","author":"Kumar","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/cns.12374","article-title":"Peroxisome proliferator-activated receptor-\u0393 agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats","volume":"21","author":"Lan","year":"2015","journal-title":"CNS Neurosci. Therapeut."},{"key":"B77","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1515\/revneuro-2013-0011","article-title":"Does the dopamine hypothesis explain schizophrenia?","volume":"24","author":"Lau","year":"2013","journal-title":"Rev. Neurosci."},{"key":"B78","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ene.12344","article-title":"A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis","volume":"21","author":"Lenglet","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1523\/JNEUROSCI.3608-15.2016","article-title":"Clemastine enhances myelination in the prefrontal cortex and rescues behavioral changes in socially isolated mice","volume":"36","author":"Liu","year":"2016","journal-title":"J. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jpsychires.2010.07.007","article-title":"Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study","volume":"45","author":"Luck","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1038\/srep12079","article-title":"Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion","volume":"5","author":"Ma","year":"2015","journal-title":"Sci. Rep."},{"key":"B83","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuropharm.2016.09.009","article-title":"Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules","volume":"111","author":"Magalon","year":"2016","journal-title":"Neuropharmacology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/hipo.20873","article-title":"Hippocampal volumetrics in treatment-resistant depression and schizophrenia: the devil's In de-tail","volume":"22","author":"Maller","year":"2012","journal-title":"Hippocampus"},{"key":"B85","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4306\/pi.2016.13.2.247","article-title":"Age of onset in schizophrenia spectrum disorders: complex interactions between genetic and environmental factors","volume":"13","author":"Mandelli","year":"2016","journal-title":"Psychiatry Investig."},{"key":"B86","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphar.2016.00231","article-title":"MSCS-derived exosomes: cell-secreted nanovesicles with regenerative potential","volume":"7","author":"Marote","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cortex.2009.07.015","article-title":"Anatomic dissection of the inferior fronto-occipital fasciculus revisited in the lights of brain stimulation data","volume":"46","author":"Martino","year":"2010","journal-title":"Cortex"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ctrv.2017.09.010","article-title":"Chemotherapy-induced cognitive impairments: white matter pathologies","volume":"61","author":"Matsos","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2012.05.048","article-title":"Cd44 expression in astrocytes and microglia is associated with als progression in a mouse model","volume":"520","author":"Matsumoto","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B90","doi-asserted-by":"publisher","first-page":"E38172","DOI":"10.1371\/journal.pone.0038172","article-title":"Identification of sialyltransferase 8b as a generalized susceptibility gene for psychotic and mood disorders on chromosome 15q25-26","volume":"7","author":"Mcauley","year":"2012","journal-title":"PLOS ONE"},{"key":"B91","first-page":"3619","author":"McEvoy","year":"2012","journal-title":"Drug Information"},{"key":"B92","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.schres.2015.01.029","article-title":"White matter changes in first episode psychosis and their relation to the size of sample studied: a DTI study","volume":"162","author":"Melicher","year":"2015","journal-title":"Schizophr. Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2013the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr. Med. Res. Opin."},{"key":"B94","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.schres.2006.06.016","article-title":"White matter fractional anisotropy and outcome in schizophrenia","volume":"87","author":"Mitelman","year":"2006","journal-title":"Schizophr. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.schres.2009.07.021","article-title":"A longitudinal study of the corpus callosum in chronic schizophrenia","volume":"114","author":"Mitelman","year":"2009","journal-title":"Schizophr. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.schres.2006.12.029","article-title":"Internal capsule, corpus callosum and long associative fibers in good and poor outcome schizophrenia: a diffusion tensor imaging survey","volume":"92","author":"Mitelman","year":"2007","journal-title":"Schizophr. Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.07.013","article-title":"Polymerized nano-curcumin attenuates neurological symptoms in eae model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair","volume":"99","author":"Mohajeri","year":"2015","journal-title":"Neuropharmacology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.pnpbp.2007.08.017","article-title":"Differential clinical, structural and p300 parameters in schizophrenia patients resistant to conventional neuroleptics","volume":"32","author":"Molina","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B99","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.neuron.2006.08.012","article-title":"Principles of diffusion tensor imaging and its applications to basic neuroscience research","volume":"51","author":"Mori","year":"2006","journal-title":"Neuron"},{"key":"B100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3371\/CSRP.4.1.4","article-title":"Clozapine for treatment-resistant schizophrenia: national institute of clinical excellence (nice) guidance in the real world","volume":"4","author":"Mortimer","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"B101","doi-asserted-by":"publisher","first-page":"E1004","DOI":"10.1038\/tp.2016.279","article-title":"Meta-analysis reveals associations between genetic variation in the 5' and 3' regions of neuregulin-1 and schizophrenia","volume":"7","author":"Mostaid","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"B102","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/schbul\/sbv151","article-title":"Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive","volume":"42","author":"Mouchlianitis","year":"","journal-title":"Schizophr. Bull."},{"key":"B103","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S2215-0366(15)00540-4","article-title":"Brain-imaging studies of treatment-resistant schizophrenia: a systematic review","volume":"3","author":"Mouchlianitis","year":"","journal-title":"Lancet Psychiatry"},{"key":"B104","volume-title":"Psychosis and Schizophrenia in Adults: Prevention and Management.","year":"2014"},{"key":"B105","volume-title":"Drug Record For Acetylcysteine","year":"2018"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/acn3.260","article-title":"Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes","volume":"2","author":"Natrajan","year":"2015","journal-title":"Ann Clin Transl Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1148\/radiol.2452060445","article-title":"Diffusion-tensor MR Imaging and tractography: exploring brain microstructure and connectivity","volume":"245","author":"Nucifora","year":"2007","journal-title":"Radiology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.nicl.2016.08.004","article-title":"Abnormal white matter microstructure and increased extracellular free-water in the cingulum bundle associated with delusions in chronic schizophrenia","volume":"12","author":"Oestreich","year":"2016","journal-title":"Neuroimage Clin."},{"key":"B109","doi-asserted-by":"publisher","first-page":"44433","DOI":"10.1038\/srep44433","article-title":"White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke","volume":"7","author":"Otero-Ortega","year":"2017","journal-title":"Sci. Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2013.203","article-title":"Cortical folding defects as markers of poor treatment response in first-episode psychosis","volume":"70","author":"Palaniyappan","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1523\/JNEUROSCI.4632-15.2016","article-title":"Behavioral, neurophysiological, and synaptic impairment in a transgenic Neuregulin1 (Nrg1-Iv) murine schizophrenia model","volume":"36","author":"Papaleo","year":"2016","journal-title":"J. Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1708\/2679.27441","article-title":"Alterations of cerebral white matter structure in psychosis and their clinical correlations: a systematic review of diffusion tensor imaging studies","volume":"52","author":"Parnanzone","year":"2017","journal-title":"Riv Psichiatr."},{"key":"B113","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI98761","article-title":"Micro(Glial)-managing executive function: white matter inflammation drives catatonia","volume":"128","author":"Pease-Raissi","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/schbul\/sbr126","article-title":"Eugen bleuler and the schizophrenias: 100 years after","volume":"37","author":"Peralta","year":"2011","journal-title":"Schizophr. Bull."},{"key":"B115","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/schbul\/sbs089","article-title":"Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis","volume":"39","author":"Peters","year":"2013","journal-title":"Schizophr. Bull."},{"key":"B116","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.nicl.2016.04.013","article-title":"Integrity of the arcuate fasciculus in patients with schizophrenia with auditory verbal hallucinations: a DTI-tractography study","volume":"12","author":"Psomiades","year":"2016","journal-title":"Neuroimage Clin."},{"key":"B117","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/brain\/awt310","article-title":"White matter integrity as a predictor of response to treatment in first episode psychosis","volume":"137","author":"Reis Marques","year":"2014","journal-title":"Brain"},{"key":"B118","first-page":"28","article-title":"Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies","author":"Revicki","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"B119","first-page":"53","article-title":"Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis","volume":"16","author":"Rodgers","year":"2013","journal-title":"Discov. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"8131","DOI":"10.1073\/pnas.0702157104","article-title":"Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders","volume":"104","author":"Roy","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/nbm.1700","article-title":"High-resolution diffusion tensor imaging of fixed brain in a mouse model of pelizaeus-merzbacher disease: comparison with quantitative measures of white matter pathology","volume":"24","author":"Ruest","year":"2011","journal-title":"NMR Biomed."},{"key":"B122","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3174\/ajnr.A0856","article-title":"White matter abnormalities in mild traumatic brain injury: a diffusion tensor imaging study","volume":"29","author":"Rutgers","year":"2008","journal-title":"Am. J. Neuroradiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1523\/JNEUROSCI.2661-16.2017","article-title":"Early and late loss of the cytoskeletal scaffolding protein, Ankyrin G reveals its role in maturation and maintenance of nodes of ranvier in myelinated axons","volume":"37","author":"Saifetiarova","year":"2017","journal-title":"J. Neurosci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature14957","article-title":"Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination","volume":"526","author":"Samanta","year":"2015","journal-title":"Nature"},{"key":"B125","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ptr.5025","article-title":"Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial","volume":"28","author":"Sanmukhani","year":"2014","journal-title":"Phytother. Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/glia.22847","article-title":"Oligodendroglial maldevelopment in the cerebellum after postnatal hyperoxia and its prevention by minocycline","volume":"63","author":"Scheuer","year":"2015","journal-title":"Glia"},{"key":"B127","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"B128","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/jnr.22824","article-title":"Minocycline protects oligodendroglial precursor cells against injury caused by oxygen-glucose deprivation","volume":"90","author":"Schmitz","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.expneurol.2014.01.017","article-title":"Minocycline protects the immature white matter against hyperoxia","volume":"254","author":"Schmitz","year":"2014","journal-title":"Exp. Neurol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/schbul\/sbv148","article-title":"Evidence for accelerated decline of functional brain network efficiency in schizophrenia","volume":"42","author":"Sheffield","year":"2016","journal-title":"Schizophr. Bull."},{"key":"B131","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13311-015-0409-z","article-title":"Therapeutic advances and future prospects in progressive forms of multiple sclerosis","volume":"13","author":"Shirani","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B132","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neulet.2010.01.046","article-title":"Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients","volume":"472","author":"Shukla","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/glia.23116","article-title":"The logistics of myelin biogenesis in the central nervous system","volume":"65","author":"Snaidero","year":"2017","journal-title":"Glia"},{"key":"B134","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/schbul\/sbn176","article-title":"Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring","volume":"35","author":"Stephan","year":"2009","journal-title":"Schizophr. Bull."},{"key":"B135","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-0447.2009.01389.x","article-title":"Morphology of the corpus callosum in treatment-resistant schizophrenia and major depression","volume":"120","author":"Sun","year":"2009","journal-title":"Acta Psychiatr. Scandinavica"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2012.02.013","article-title":"Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation","volume":"197","author":"Suzuki","year":"2012","journal-title":"Psychiatry Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2217\/epi-2016-0106","article-title":"Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy","volume":"9","author":"Swathy","year":"2017","journal-title":"Epigenomics"},{"key":"B138","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/glia.23048","article-title":"St8sia2 promotes oligodendrocyte differentiation and the integrity of myelin and axons","volume":"65","author":"Szewczyk","year":"2017","journal-title":"Glia"},{"key":"B139","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.schres.2018.02.054","article-title":"Clozapine use in early psychosis","volume":"199","author":"Thien","year":"2018","journal-title":"Schizophr. Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1517\/14656566.2011.528200","article-title":"Pharmacotherapy for treatment-refractory schizophrenia","volume":"12","author":"Van Sant","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"B141","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.nicl.2018.01.010","article-title":"White matter changes in treatment refractory schizophrenia: does cognitive control and myelination matter?","volume":"18","author":"Vanes","year":"2018","journal-title":"Neuroimage Clin."},{"key":"B142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.schres.2016.04.023","article-title":"Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: a post-mortem morphometric study","volume":"177","author":"Vikhreva","year":"2016","journal-title":"Schizophr. Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1212\/01.wnl.0000324414.12665.b0","article-title":"Fish consumption and risk of subclinical brain abnormalities on MRI in older adults","volume":"71","author":"Virtanen","year":"2008","journal-title":"Neurology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1176\/appi.ajp.159.2.255","article-title":"Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder","volume":"159","author":"Volavka","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"B145","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.schres.2017.12.004","article-title":"Substantia nigra ultrastructural pathology in schizophrenia","volume":"197","author":"Walker","year":"2018","journal-title":"Schizophr Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2013.10.018","article-title":"White matter plasticity in adulthood","volume":"276","author":"Wang","year":"2014","journal-title":"Neuroscience"},{"key":"B147","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.schres.2014.08.033","article-title":"Cingulum bundle integrity associated with delusions of control in schizophrenia: preliminary evidence from diffusion-tensor tractography","volume":"161","author":"Whitford","year":"2015","journal-title":"Schizophr. Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nicl.2014.06.003","article-title":"Localized abnormalities in the cingulum bundle in patients with schizophrenia: a diffusion tensor tractography study","volume":"5","author":"Whitford","year":"2014","journal-title":"Neur. Clin."},{"key":"B149","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0706743716651049","article-title":"What is the place of clozapine in the treatment of early psychosis in Canada?","volume":"62","author":"Williams","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"B150","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.euroneuro.2016.11.012","article-title":"Adjunctive minocycline for schizophrenia: a meta-analysis of randomized controlled trials","volume":"27","author":"Xiang","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.intimp.2010.08.013","article-title":"Curcumin has bright prospects for the treatment of multiple sclerosis","volume":"11","author":"Xie","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnbeh.2011.00031","article-title":"Recovery of behavioral changes and compromised white matter in C57bl\/6 mice exposed to cuprizone: effects of antipsychotic drugs","volume":"5","author":"Xu","year":"2011","journal-title":"Front. Behav. Neurosci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"E0139413","DOI":"10.1371\/journal.pone.0139413","article-title":"Association between St8sia2 and the risk of schizophrenia and bipolar I disorder across diagnostic boundaries","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS ONE"},{"key":"B154","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ajmg.b.30274","article-title":"Genetic association between schizophrenia and the DISC1 gene in the Scottish population","author":"Zhang","year":"2006","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"B155","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jnr.24189","article-title":"N-acetylcysteine attenuates the cuprizone-induced behavioral changes and oligodendrocyte loss in male C57bl\/7 mice via its anti-inflammation actions","volume":"96","author":"Zhang","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuroimage.2012.11.056","article-title":"Prefrontal white matter impairment in substance users depends upon the Catechol-O-Methyl transferase (Comt) Val158met polymorphism","volume":"69","author":"Zhang","year":"2013","journal-title":"Neuroimage"}],"updated-by":[{"DOI":"10.3389\/fphar.2018.01417","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T15:33:38Z","timestamp":1543937618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":156,"alternative-id":["10.3389\/fphar.2018.01172"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01172","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2018.01417","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"article-number":"1172"}}